Biotech ETF (XBI) Outperforms, Up 3.75%
Tweet
Share
E-mailBiotech ETF (XBI) Outperforms, Up 3.75%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs to acquire Neos in $2.3B deal
- Goldman Sachs warns AI investment may be crowding out other business spending
- Intel (INTC) Said To Target At Least $95 A Share In $20b Share Sale - Bloomberg
Create E-mail Alert Related Categories
ETFs, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
